Dr. Khalid Kayani MD

Recommended Articles

• Pink Chair Project Celebrates Survivors of Breast Cancer

  Breast cancer is the most common type of cancer among American women, with the exception of skin cancers. It is also the second leading cause of death among women, after lung cancer. The American Cancer Society estimates that there are over 3.1 million breast cancer survivors in the United States,...

• Painkillers Can Increase Your Risk of Miscarriages

  Use of non-aspirin anti-inflammatory painkillers may increase the risk of miscarriages in women, according to a new study published in the Canadian Medical Association Journal. This new study is large with more than 52,000 pregnant women from Canada. The study results show that women who had...

• Children May Have Asthma Because of Their Mother's Health Before and During Pregnancy

  A new study has shown that children born from women who were overweight or obese during pregnancy has a higher risk of getting asthma during adolescence. The study conducted by the researchers from Britain, Finland, and Sweden shows that an individual's weight before pregnancy influences the...

• Treating PCOS With Progestin Decreases the Chances of Pregnancy

  PCOS is a common medical problem faced by women. It is usually caused by an imbalance in reproductive hormones. This imbalance can lead to problems in the ovaries. In a normal state, the ovaries make the egg and release it every month as part of a healthy menstrual cycle, however, for those with...

• Is Hormone Replacement Therapy Preventing Women from Getting Mammograms?

  According to a new study, the sudden drop in the rate of mammograms taken by women is due to the fear of hormone replacement therapy (HRT). Up to the year 2000, many women used to take up mammography, once every two years, as a screening method for breast cancer. By the year 2005, researchers...

• Can Melatonin Keep Breast Cancer at Bay and Improve Treatment?

  Breast cancer is the most common type of cancer among women. Today, this type of cancer generally has a good prognosis: around 80% of women have a survival rate of 10 years or longer. This is partially due to the chemotherapeutic agent known as tamoxifen. ...